• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: The Burden of Postoperative Complications in Cytoreductive Surgery for Advanced Ovarian Carcinoma: Are we Measuring it Accurately?

作者信息

Bianchi Tommaso, Fruscio Robert

机构信息

Department of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy.

UO Gynecology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.

出版信息

Ann Surg Oncol. 2025 Sep;32(9):6616-6617. doi: 10.1245/s10434-025-17678-y. Epub 2025 Jun 21.

DOI:10.1245/s10434-025-17678-y
PMID:40544209
Abstract
摘要

相似文献

1
ASO Author Reflections: The Burden of Postoperative Complications in Cytoreductive Surgery for Advanced Ovarian Carcinoma: Are we Measuring it Accurately?ASO作者反思：晚期卵巢癌细胞减灭术的术后并发症负担：我们的测量准确吗？
Ann Surg Oncol. 2025 Sep;32(9):6616-6617. doi: 10.1245/s10434-025-17678-y. Epub 2025 Jun 21.
2
Optimal primary surgical treatment for advanced epithelial ovarian cancer.晚期上皮性卵巢癌的最佳初次手术治疗
Cochrane Database Syst Rev. 2011 Aug 10;2011(8):CD007565. doi: 10.1002/14651858.CD007565.pub2.
3
Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced epithelial ovarian cancer.晚期上皮性卵巢癌初始治疗中，术前新辅助化疗与手术加化疗的比较。
Cochrane Database Syst Rev. 2025 Feb 10;2(2):CD005343. doi: 10.1002/14651858.CD005343.pub7.
4
Postoperative Complications After Cytoreductive Surgery for Advanced Ovarian Carcinoma: A Single-Center Analysis Exploring the Value of the Comprehensive Complication Index and the Predictors of High Complications Burden.晚期卵巢癌肿瘤细胞减灭术后的并发症：一项探索综合并发症指数价值及高并发症负担预测因素的单中心分析
Ann Surg Oncol. 2025 Jun 24. doi: 10.1245/s10434-025-17619-9.
5
Effectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancer.氨甲环酸在晚期卵巢癌肿瘤细胞减灭术中减少失血的有效性。
Cochrane Database Syst Rev. 2016 Jan 23;2016(1):CD011732. doi: 10.1002/14651858.CD011732.pub2.
6
Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.晚期卵巢上皮癌初始治疗中化疗与手术的比较
Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD005343. doi: 10.1002/14651858.CD005343.pub3.
7
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
8
Surgical cytoreduction for recurrent epithelial ovarian cancer.复发性上皮性卵巢癌的手术细胞减灭术。
Cochrane Database Syst Rev. 2013 Feb 28;2013(2):CD008765. doi: 10.1002/14651858.CD008765.pub3.
9
Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.超根治性（广泛）手术与标准手术治疗晚期上皮性卵巢癌的初步细胞减灭术。
Cochrane Database Syst Rev. 2022 Aug 30;8(8):CD007697. doi: 10.1002/14651858.CD007697.pub3.
10
Pegylated liposomal doxorubicin for first-line treatment of epithelial ovarian cancer.聚乙二醇化脂质体阿霉素用于上皮性卵巢癌的一线治疗。
Cochrane Database Syst Rev. 2013 Oct 21;2013(10):CD010482. doi: 10.1002/14651858.CD010482.pub2.

本文引用的文献

1
The comprehensive complication index: a novel continuous scale to measure surgical morbidity.综合并发症指数：一种新型连续量表，用于衡量手术发病率。
Ann Surg. 2013 Jul;258(1):1-7. doi: 10.1097/SLA.0b013e318296c732.
2
The accordion severity grading system of surgical complications.手术并发症的手风琴严重程度分级系统。
Ann Surg. 2009 Aug;250(2):177-86. doi: 10.1097/SLA.0b013e3181afde41.
3
Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.手术并发症的分类：一项在6336例患者队列中进行评估的新提议及一项调查结果
Ann Surg. 2004 Aug;240(2):205-13. doi: 10.1097/01.sla.0000133083.54934.ae.